Monoclonal Anti body therapy

This is has an acronym of TKs are the one of the newer form of treatments that is being discovered in the field of medical sciences to treat the cancer. It is clearly explained that alteration is certain normal pathways in the functionalities of the human bodies induce cancer cells to grow in the human body. TKs are of greater importance in signal transduction pathways and hence it follows the necessary action that has an ability to switch the abnormal pathways or switch off the active pathways of the cancer cells. One such TK agents that have been discovered are the Imatinib. This effective usage of TK has been remarkably successful in treating myeloid leukemia and gastro intestinal stromal tumors. Other TK agents such as Gefitinib and eritonib are also being evaluated in several clinical concerns for treating certain types of cancers. Of course this cannot be used to treat all types of cancer and hence the oncologist should evaluate the patient properly before starting the course of the treatments.